TRML Dividend: Tourmaline Bio Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TRML Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	22	23	13	19	13	7
Research & Development	79	66	32	56	34	15
Operating Expenses	102	90	45	76	47	22
Other Non Operating Income (Expenses)	13	17	3	1	-1	0
Pretax Income	-88	-73	-42	-73	-47	-22
Income Tax Expense	--	--	--	--	--	--
Net Income	-88	-73	-42	-73	-47	-22
Net Income Growth	151%	74%	-42%	55%	113.99%	22%
Shares Outstanding (Diluted)	26	25	4.75	4.12	4.09	4.12
Shares Change (YoY)	0%	426%	15%	1%	-1%	0%
EPS (Diluted)	-3.38	-2.92	-8.84	-17.93	-11.69	-5.51
EPS Growth	150%	-67%	-51%	53%	112%	25%
Free Cash Flow	-86	-77	-28	-63	-42	-20
Free Cash Flow Per Share	-3.3	-3.08	-5.89	-15.29	-10.26	-4.85
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-102	-90	-45	-75	-47	-22
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	1	0	0
EBIT	-102	-90	-45	-76	-47	-22
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--